RTW Investments LP increased its stake in shares of ViewRay, Inc. (NASDAQ:VRAY) by 33.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,020,462 shares of the company’s stock after acquiring an additional 256,127 shares during the quarter. ViewRay makes up 1.0% of RTW Investments LP’s investment portfolio, making the stock its 21st largest position. RTW Investments LP owned approximately 1.73% of ViewRay worth $5,878,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently bought and sold shares of the company. Geode Capital Management LLC lifted its stake in shares of ViewRay by 158.7% in the 1st quarter. Geode Capital Management LLC now owns 149,463 shares of the company’s stock valued at $1,271,000 after purchasing an additional 91,694 shares during the period. UBS Group AG increased its position in ViewRay by 447.7% during the 1st quarter. UBS Group AG now owns 22,479 shares of the company’s stock valued at $192,000 after buying an additional 18,375 shares in the last quarter. Goldman Sachs Group Inc. bought a new position in ViewRay during the 1st quarter valued at approximately $484,000. Russell Investments Group Ltd. bought a new position in ViewRay during the 2nd quarter valued at approximately $1,361,000. Finally, Schwab Charles Investment Management Inc. bought a new position in ViewRay during the 2nd quarter valued at approximately $323,000. Institutional investors and hedge funds own 50.08% of the company’s stock.

Shares of ViewRay, Inc. (VRAY) opened at $8.79 on Wednesday. ViewRay, Inc. has a fifty-two week low of $3.01 and a fifty-two week high of $10.39. The company has a debt-to-equity ratio of -1.67, a quick ratio of 1.20 and a current ratio of 1.59.

ViewRay (NASDAQ:VRAY) last posted its earnings results on Monday, November 13th. The company reported ($0.19) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.07). The business had revenue of $12.20 million during the quarter, compared to analyst estimates of $18.63 million. ViewRay’s revenue for the quarter was up 2950.0% on a year-over-year basis. analysts predict that ViewRay, Inc. will post -0.91 EPS for the current fiscal year.

A number of research analysts recently weighed in on the company. ValuEngine lowered ViewRay from a “hold” rating to a “sell” rating in a research report on Friday, December 1st. Northland Securities reaffirmed a “buy” rating and set a $10.00 price objective on shares of ViewRay in a research report on Friday, November 17th. Finally, Mizuho reaffirmed a “buy” rating and set a $12.00 price objective on shares of ViewRay in a research report on Monday, November 13th. One research analyst has rated the stock with a sell rating and five have issued a buy rating to the stock. ViewRay currently has an average rating of “Buy” and an average price target of $10.60.

ILLEGAL ACTIVITY NOTICE: “RTW Investments LP Buys 256,127 Shares of ViewRay, Inc. (VRAY)” was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://theolympiareport.com/2017/12/06/rtw-investments-lp-buys-256127-shares-of-viewray-inc-vray.html.

ViewRay Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Institutional Ownership by Quarter for ViewRay (NASDAQ:VRAY)

Receive News & Ratings for ViewRay Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ViewRay Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.